GlassScriptPhysician profile
William B Liles
NPI 1710197033
$6,069.94
in general payments reported to CMS, 2019-2025
16 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $256 · 2021: $345 · 2022: $303 · 2023: $3,249 · 2024: $1,314 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,081 · Travel and Lodging: $721 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,081.23 |
| Travel and Lodging | $721.20 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,634.18 | 2019-2024 | Davinci Xi |
| Bard Peripheral Vascular, INC. | $389.33 | 2021-2025 | Venclose Maven Catheter, Atlas |
| Davol INC. | $385.44 | 2020-2023 | Phasix Mesh |
| Ethicon US, LLC | $176.17 | 2019-2025 | Stratafix |
| Medtronic Vascular, INC. | $132.73 | 2019 | |
| Tactile Systems Technology INC | $67.33 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Kerecis Limited | $44.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Becton, Dickinson and Company | $40.49 | 2024 | Venclose Maven Catheter |
| Smith+Nephew, INC. | $38.26 | 2025 | Renasys Touch, Pico 14, Pico 7 |
| Abbvie INC. | $33.28 | 2021 | |
| Mindray Ds USA, INC. | $31.91 | 2023 | Te X, Te7 Max |
| Medtronic, INC. | $28.47 | 2023-2024 | Aquamantys(Tm), Plasmablade(Tm) |
| Kci USA, INC. | $20.59 | 2023 | Prevena |
| Hologic INC | $17.49 | 2022 | |
| Karl Storz Endoscopy-America | $15.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $14.03 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Liles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.